mitoxantrone has been researched along with Angiofollicular Lymph Hyperplasia in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cervigón, I | 1 |
| Palomo, A | 1 |
| Torres-Iglesias, LM | 1 |
| Solano, F | 1 |
| Zapata, AM | 1 |
| Casarotto, D | 1 |
| Bottio, T | 1 |
| Gambino, A | 1 |
| Testolin, L | 1 |
| Gerosa, G | 1 |
1 review available for mitoxantrone and Angiofollicular Lymph Hyperplasia
| Article | Year |
|---|---|
[Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined C | 2011 |
1 other study available for mitoxantrone and Angiofollicular Lymph Hyperplasia
| Article | Year |
|---|---|
The last to die is hope: prolonged mechanical circulatory support with a Novacor left ventricular assist device as a bridge to transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cardiomyopathy, Dilated; Castleman Di | 2003 |